Vincente E.
- Country
- Spain
- Department
- Enfermedades Infecciosas
Research Overview
- An Operationally Seamless Phase 2/3 Randomized, Open-label, Multicenter, Active-Controlled Study to Evaluate the Safety and Efficacy of Bictegravir/Lenacapavir Versus Stable Baseline Regimen in Virologically Suppressed People With HIV-1 on Stable Complex Treatment Regimens
- European Randomised Clinical Trial on mPOX Infection (EPOXI)
- A Phase II Randomized, Double‑Blind, Placebo‑Controlled Study of Dasatinib to Reduce HIV‑1 Reservoir, Chronic Inflammation and Immune Senescence in ART‑suppressed Adults
Data & Insights
Has run more than one trial at 91 of 274 partner sites.
Specializations
Viral Infections Treatment
The investigator specializes in treating HIV-1 infections, focusing on innovative therapeutic approaches and treatment optimization for patients with varying response levels. Their work encompasses evaluation of novel oral and long-acting medications for both treatment-naïve and treatment-experienced patients.
- Antiretroviral therapy optimization
- Long-acting HIV treatments
- Novel therapeutic compounds
The research extends to studying treatment options for patients with chronic HIV infection and those with suboptimal responses to conventional therapies.
Respiratory Disease Prevention
The investigator conducts research in preventive medicine for respiratory conditions, with particular emphasis on vaccine effectiveness against pneumococcal disease and viral respiratory infections. Their work includes evaluation of conjugate vaccines and innovative preventive approaches.
- Pneumococcal conjugate vaccines
- RSV and hMPV prevention
- Community-acquired pneumonia
Their research focuses on protecting vulnerable populations, particularly older adults, against respiratory pathogens.
Emerging Infectious Diseases
The investigator studies emerging viral infections and their treatment approaches, including research on COVID-19 and monkeypox. Their work encompasses evaluation of novel therapeutic agents and prophylactic treatments for these conditions.
- COVID-19 therapeutics
- Monkeypox treatment
- Preventive antibody therapies
The research includes assessment of outpatient treatments and prophylactic approaches for high-risk populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.